Ardelyx Receives New Patent for Tenapanor [Yahoo! Finance]
Ardelyx, Inc. (ARDX)
Last ardelyx, inc. earnings: 3/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ardelyx.com/investor-relations
Company Research
Source: Yahoo! Finance
biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,539,299 titled “Oral Formulations of Tenapanor” with an expiration date of November 26, 2042. The patent relates to the formulation of tenapanor and covers the commercial formulations of IBSRELA ® (tenapanor) and XPHOZAH ® (tenapanor). The patent will be submitted to the Food and Drug Administration for listing in the Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book) for both products. “We are pleased to have been granted this patent for IBSRELA and XPHOZAH, which expires in fall of 2042,” said Mike Raab, president and chief executive officer of Ardelyx. “This is an important step in extending protections for our portfolio of first-in-class medicines in therapeutic
Show less
Read more
Impact Snapshot
Event Time:
ARDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARDX alerts
High impacting Ardelyx, Inc. news events
Weekly update
A roundup of the hottest topics
ARDX
News
- Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 [Yahoo! Finance]Yahoo! Finance
- Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026GlobeNewswire
- Ardelyx Receives New Patent for TenapanorGlobeNewswire
- Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results [Yahoo! Finance]Yahoo! Finance
- Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at TD Cowen.MarketBeat
ARDX
Earnings
- 10/30/25 - Beat
ARDX
Sec Filings
- 1/30/26 - Form SCHEDULE
- 1/27/26 - Form 4
- 1/26/26 - Form 4
- ARDX's page on the SEC website